JAMIE SHADDIX: Open Payments
NPI 1841887551 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 17 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $86 |
| TerSera Therapeutics LLC | 2 | $40 |
| Octapharma USA, Inc. | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $23 |
| Invivyd Inc | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: EMBLAVEO, Quzyttir, PANZYGA, VOWST, ZERBAXA, CUVITRU, Yeztugo, PEMGARDA.
Industry payments across KS — which companies pay providers there.
